Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
(2007 - 2011)
2022
2018 - 2022
2020 - 2022
2018 - 2020
2018 - 2018
2018 - 2018
2018 - 2018
Conducted equity research, created financial models, and analyzed science and market landscapes to value small to mid-sized biotechnology companies
2016 - 2018
2016 - 2018
Developed valuation frameworks, including analysis of clinical trial data, scientific differentiators, and market landscape to identify biotechnology companies with advantageous risk/reward and growth opportunities